1    INTRODUCTION    

    1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources
 

2 Research Methodology
    2.1 Research Approach
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Proteomics Market Size Estimation
    2.3 Proteomics Market Breakdown and Data Triangulation
    2.4 Proteomics Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 Global Proteomics Market Overview
    4.2 Asia-Pacific: Proteomics Market Share, By Application (2017)
    4.3 Geographic Snapshot of the Proteomics Market
    4.4 Geographic Mix: Proteomics Market
    4.5 Proteomics Market: Developed vs Developing Countries

5 Market Overview
    5.1 Introduction
    5.2 Key Proteomics Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Increasing Demand for Personalized Medicine
                    5.2.1.2 Proteomics Bridges the Gap Between Genome Sequence and Cellular Behavior
                    5.2.1.3 Increasing Pharmaceutical and Biotech R&D Expenditure
                    5.2.1.4 Technological Advancements
                    5.2.1.5 Availability of Government and Private Funding
           5.2.2 Key Market Restraints
                    5.2.2.1 Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research
                    5.2.2.2 Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
                    5.2.2.3 Expensive Tools and Instruments and Their Maintenance
           5.2.3 Key Market Opportunities
                    5.2.3.1 Growing Applications of Nanotechnology
                    5.2.3.2 Biomarker Identification
                    5.2.3.3 Untapped Emerging Markets
           5.2.4 Key Market Challenges
                    5.2.4.1 Managing Large Volumes of Data Generated in Proteomics Research
                    5.2.4.2 Dearth of Skilled Researchers and Mandatory Training Cost

6 Industry Insights
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Shift From Genomics to Proteomics
           6.2.2 Growing Number of Collaborations in Proteomics Market
    6.3 Product Portfolio Analysis
    6.4 Regulatory Analysis
           6.4.1 North America

7 Global Proteomics Market, By Instrumentation Technology
    7.1 Introduction
    7.2 Protein Microarrays
           7.2.1 Biochips
                    7.2.1.1 Protein Chips
                    7.2.1.2 Lab-On-Chips (Microfluidics)
           7.2.2 Microarray Instruments
                    7.2.2.1 Integrated Systems
                    7.2.2.2 Arrayers
                    7.2.2.3 Microarray Scanners
    7.3 Spectroscopy
           7.3.1 Mass Spectrometry
           7.3.2 NMR Spectroscopy
           7.3.3 CD Spectroscopy
    7.4 X-Ray Crystallography
    7.5 Chromatography
           7.5.1 HPLC
           7.5.2 Ion Chromatography
           7.5.3 Affinity Chromatography
           7.5.4 Supercritical Fluid Chromatography
    7.6 Electrophoresis
           7.6.1 Gel Electrophoresis
           7.6.2 Capillary Electrophoresis
    7.7 Surface Plasmon Resonance (SPR)
    7.8 Protein Fractionation

8 Global Proteomics Market, By Reagent
    8.1 Introduction
    8.2 Protein Microarray Reagents
    8.3 Spectroscopy Reagents
    8.4 X-Ray Crystallography Reagents
    8.5 Chromatography Reagents
    8.6 Electrophoresis Reagents
    8.7 Immunoassay Reagents
    8.8 Protein Fractionation Reagents

9 Global Proteomics Market, By Services and Software
    9.1 Introduction
    9.2 Analytical Laboratory Services
           9.2.1 Protein Identification
           9.2.2 Protein Separation
           9.2.3 Protein Sequencing
    9.3 Data Analysis & Maintenance
           9.3.1 Bioinformatics Databases
           9.3.2 Bioinformatics Tools
    9.4 Quantitation Services

10 Global Proteomics Market, By Application
     10.1 Introduction
     10.2 Drug Discovery
     10.3 Clinical Diagnostics
     10.4 Other Proteomics Applications

11 Global Proteomics Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 Italy
             11.3.4 U.K.
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific
             11.4.1 China
             11.4.2 India
             11.4.3 Japan
             11.4.4 Rest of Asia-Pacific
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa

12 Competitive Landscape
     12.1 Overview
     12.2 Strategic Benchmarking
             12.2.1 Increasing Focus on Product Launches and Enhancements
     12.3 Market Ranking Analysis
             12.3.1 Proteomic Instrumentation Technology
             12.3.2 Proteomic Reagents
             12.3.3 Proteomics Services and Software
     12.4 Competitive Situations and Trends
             12.4.1 Product Launches and Enhancements
             12.4.2 Partnerships, Agreements, Collaborations, and Alliances
             12.4.3 Acquisitions
             12.4.4 Expansions

13 Company Profiles

     13.1 Introduction
     13.2 Thermo Fisher Scientific, Inc.
     13.3 Agilent Technologies, Inc.
     13.4 Bio-Rad Laboratories, Inc.
     13.5 Merck KGaA
     13.6 Danaher Corporation
     13.7 Luminex Corporation
     13.8 Perkinelmer, Inc.
     13.9 Waters Corporation
     13.10 GE Healthcare
     13.11 Bruker Corporation